SCHEMBL5033052

SCHEMBL5033052

CCc1cc(C(N)=O)c(CC)c(F)c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
DGAT1 O75907 1/20 0.34
MAPT P10636 3/20 0.34
HTT P42858 2/20 0.34
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
ATM Q13315 1/20 0.33
PARP1 P09874 2/20 0.33
CDC7 O00311 1/20 0.33
MAP2K2 P36507 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29175226 0.86 SMN1; SMN2 (0.36) SMN1; SMN2DGAT1MAPTHTTKDM4E
SCHEMBL29175217 0.81 DGAT1 (0.38) SMN1; SMN2DGAT1HTTLMNACES2
SCHEMBL27539515 0.80 GRIN2D (0.38) SMN1; SMN2MAPTHTTKDM4ELMNA
SCHEMBL29175211 0.80 NNMT (0.33) SMN1; SMN2DGAT1PARP1CDC7MAP2K2
SCHEMBL27856987 0.79 DGAT1 (0.39) SMN1; SMN2DGAT1HTTLMNACES2
SCHEMBL6186161 0.79 PARP1 (0.41) SMN1; SMN2DGAT1MAPTHTTKDM4E
SCHEMBL27539502 0.79 GRIN2D (0.37) SMN1; SMN2MAPTHTTKDM4ELMNA
SCHEMBL29175216 0.78 SMN1; SMN2 (0.34) SMN1; SMN2DGAT1MAPTHTTKDM4E
SCHEMBL11461751 0.78 DGAT1 (0.38) DGAT1PARP1CDC7MAP2K2MAP2K1
Hydrochloric Acid SCHEMBL28556037 0.76 DGAT1 (0.37) DGAT1PARP1CDC7MAP2K2MAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110143941-B Synthesis method of intermediate of balusavir mefene 北京四环制药有限公司 2021-05-25 CN disclosed
CN-110143941-A A kind of synthetic method of Barrow Sa Weimabo ester intermediate 北京四环制药有限公司 2019-08-20 CN disclosed
EP-2001866-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2008-12-17 EP disclosed
WO-2007117982-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2007-10-18 WO disclosed